A tighter archive for life-science signals.
Search once, then narrow by source or topic.
UK-US drug pricing deal could come as early as this week, sources say
A major drug price deal between the US and UK government could be finalized as early as this week, two UK-based sources familiar with the matter told Endpoints News on...
Teva loses IRA drug pricing challenge in DC federal court
Teva’s challenge against Medicare negotiations fell flat in DC federal court, marking another loss for the pharma industry. US District Judge Sparkle Sooknanan said Thu...
Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial
Contineum Therapeutics reported a Phase 2 failure in multiple sclerosis on Thursday afternoon, but most analysts don’t seem to view the miss as catastrophic. Contineum...
GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal
GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014. On Thursday, GSK said T...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page